by In2Pharma | Oct 26, 2021 | News
The Netherlands The reporting form of the Medicine Shortages and Defects Reporting Center has been made more user-friendly. Some questions were deleted (e.g. address details of the company), textual changes were done, some questions were added and changes to the...
by In2Pharma | Apr 14, 2017 | News
FMEB and IGZ On January 2nd 2017, the Medicine shortages and defects notification centre went live. The centre is coordinated by the Medicines Evaluation Board (MEB) and the Health Care Inspectorate (IGZ). Via one central point, marketing authorisation holders and...
